Literature DB >> 22506839

Computerized assessment facilitates disclosure of sensitive HIV risk behaviors among African Americans entering substance abuse treatment.

Diana H Caldwell1, Gryczynski Jan.   

Abstract

BACKGROUND: Individuals entering substance abuse treatment are at elevated risk for HIV infection, and clinicians must generally rely on patient self-report to gauge their involvement in risk behaviors. Strategies to improve accurate reporting of personally sensitive or stigmatizing risk behaviors are needed.
OBJECTIVE: This study compared computerized and face-to-face interview methods in eliciting self-disclosure of HIV risk behaviors among a high-risk sample of urban African Americans entering substance abuse treatment (N = 146).
METHODS: Participants completed a standardized HIV risk behavior screening as a face-to-face interview. Several days later, the same participants completed a computerized self-interview with the same measure, covering the same time frame.
RESULTS: Disclosure rates for many sensitive risk behaviors were considerably higher on the computerized interview. Participants had significantly higher odds of disclosure on the computerized interview compared to the face-to-face interview on 2 of 6 drug risk behaviors examined (ORs between 2.75 and 3.15) and 9 of 13 sex risk behaviors examined (ORs between 1.60 and 6.45). The advantage of the computerized interview was most evident for highly stigmatized behaviors, such as unprotected sex with someone other than a spouse or main partner (OR = 3.93; p < .001), unprotected sex during a commercial sex transaction (OR = 5.63; p < .001), unprotected anal sex (OR = 6.45; p < .001), and using unsterilized syringes (OR = 3.15; p < .05). CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE: Findings support the utility of computerized risk behavior assessment with African Americans entering substance abuse treatment. Computerized assessment of HIV risk behaviors may be clinically useful in substance abuse treatment and other healthcare venues serving high-risk populations.

Entities:  

Mesh:

Year:  2012        PMID: 22506839     DOI: 10.3109/00952990.2012.673663

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  11 in total

Review 1.  Technology-delivered adaptations of motivational interviewing for health-related behaviors: A systematic review of the current research.

Authors:  Rebecca M Shingleton; Tibor P Palfai
Journal:  Patient Educ Couns       Date:  2015-08-06

2.  Impact of a brief intervention on reducing alcohol use and increasing alcohol treatment services utilization among alcohol- and drug-using adult emergency department patients.

Authors:  Roland C Merchant; Justin Romanoff; Zihao Zhang; Tao Liu; Janette R Baird
Journal:  Alcohol       Date:  2017-09-23       Impact factor: 2.405

3.  Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community.

Authors:  Sandra A Springer; Frederick L Altice; Maua Herme; Angela Di Paola
Journal:  Contemp Clin Trials       Date:  2013-12-31       Impact factor: 2.226

4.  Short-term Efficacy of a Brief Intervention to Reduce Drug Misuse and Increase Drug Treatment Utilization Among Adult Emergency Department Patients.

Authors:  Roland C Merchant; Janette R Baird; Tao Liu
Journal:  Acad Emerg Med       Date:  2015-09-16       Impact factor: 3.451

5.  Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.

Authors:  Sandra A Springer; Angela Di Paola; Marwan M Azar; Russell Barbour; Breanne E Biondi; Maureen Desabrais; Thomas Lincoln; Daniel J Skiest; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

6.  Immediate Versus Delayed Computerized Brief Intervention for Illicit Drug Misuse.

Authors:  Jan Gryczynski; Kevin E O'Grady; Shannon Gwin Mitchell; Steven J Ondersma; Robert P Schwartz
Journal:  J Addict Med       Date:  2016 Sep-Oct       Impact factor: 3.702

7.  Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.

Authors:  Angela Di Paola; Thomas Lincoln; Daniel J Skiest; Maureen Desabrais; Frederick L Altice; Sandra A Springer
Journal:  Contemp Clin Trials       Date:  2014-09-18       Impact factor: 2.226

8.  The Patient Reported Outcomes as a Clinical Tool (PROACT) Pilot Study: What Can be Gained by Sharing Computerized Patient-Reported Mental Health and Substance Use Symptoms with Providers in HIV Care?

Authors:  Sarah M Jabour; Geetanjali Chander; Kristin A Riekert; Jeanne C Keruly; Kayla Herne; Heidi Hutton; Mary Catherine Beach; Bryan Lau; Richard D Moore; Anne K Monroe
Journal:  AIDS Behav       Date:  2021-02-09

9.  HIV incidence among men who have sex with men using geosocial networking smartphone application in Beijing, China: an open cohort study.

Authors:  Guo-Dong Mi; Bin-Bin Zhang; Fei Yu; Xian-Long Ren; Jason J Ong; Ya-Qi Fan; Feng-Hua Guo; Chun-Jun Li; Mian-Zhi Zhang; Min-Ying Zhang
Journal:  Infect Dis Poverty       Date:  2021-04-02       Impact factor: 4.520

10.  Variations in Substance Use Prevalence Estimates and Need for Interventions among Adult Emergency Department Patients Based on Different Screening Strategies Using the ASSIST.

Authors:  Roland C Merchant; Tao Liu; Janette R Baird
Journal:  West J Emerg Med       Date:  2016-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.